Anemia, Sickle Cell

"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Descriptor ID	D000755
MeSH Number(s)	C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
Concept/Terms	Anemia, Sickle Cell Anemia, Sickle Cell Anemias, Sickle Cell Sickle Cell Anemias Hemoglobin S Disease Disease, Hemoglobin S Hemoglobin S Diseases Sickle Cell Anemia Sickle Cell Disorders Cell Disorder, Sickle Cell Disorders, Sickle Sickle Cell Disorder Sickling Disorder Due to Hemoglobin S HbS Disease Sickle Cell Disease Cell Disease, Sickle Cell Diseases, Sickle Sickle Cell Diseases

Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Hematologic Diseases [C15.378]
Anemia [C15.378.071]
Anemia, Hemolytic [C15.378.071.141]
Anemia, Hemolytic, Congenital [C15.378.071.141.150]
Anemia, Sickle Cell [C15.378.071.141.150.150]
Hemoglobinopathies [C15.378.420]
Anemia, Sickle Cell [C15.378.420.155]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Anemia, Hemolytic, Congenital [C16.320.070]
Anemia, Sickle Cell [C16.320.070.150]
Hemoglobinopathies [C16.320.365]
Anemia, Sickle Cell [C16.320.365.155]

Below are MeSH descriptors whose meaning is related to "Anemia, Sickle Cell".

Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.

Bar chart showing 63 publications over 21 distinct years, with a maximum of 5 publications in 2022 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	3	0	3
1996	2	0	2
1997	2	0	2
2005	1	2	3
2006	2	0	2
2008	4	0	4
2009	2	0	2
2010	2	1	3
2011	1	1	2
2012	3	0	3
2013	4	0	4
2014	4	0	4
2016	1	0	1
2017	2	0	2
2018	4	0	4
2019	1	2	3
2020	3	0	3
2021	4	0	4
2022	5	0	5
2023	2	0	2
2024	4	1	5

Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.

Zeng J, Nguyen MA, Liu P, da Silva LF, Levesque S, Lin LY, Justus DG, Petri K, Clement K, Porter SN, Verma A, Neri NR, Rosanwo T, Ciuculescu MF, Abriss D, Mintzer E, Maitland SA, Demirci S, Cha HJ, Orkin SH, Tisdale JF, Williams DA, Zhu LJ, Pruett-Miller SM, Pinello L, Joung JK, Pattanayak V, Manis JP, Armant M, Pellin D, Brendel C, Wolfe SA, Bauer DE. Gene editing without ex?vivo culture evades genotoxicity in human hematopoietic stem cells. Cell Stem Cell. 2025 Feb 06; 32(2):191-208.e11.

View in: PubMed
Blakey AO, Amaro CM, Eilenberg JS, Brochier A, Kavanagh PL, Garg A, Drainoni ML, Long K. Characterizing medical decision-making in sickle cell disease during childhood: Qualitative perspectives of caregivers. Pediatr Blood Cancer. 2024 Dec; 71(12):e31307.

View in: PubMed
Cohen RT, Burrowes SAB, Williams CJ, Neri CM, Klings ES, Jones KC, Walkey AJ, Drainoni ML. SNAP: Supportive non-invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team. Pediatr Blood Cancer. 2024 Sep; 71(9):e31142.

View in: PubMed
Garelnabi M, Parinandi NL. Role of Traditional Stroke Risk Factors Aiding in Prediction of Infarcts in Adult Patients With Sickle Cell Disease. J Am Heart Assoc. 2024 Jun 18; 13(12):e034798.

View in: PubMed
Olayiwola O, Castillejo A, Louella M, Supercharger M, Harlow E, Dee L, Abdallah K, Kityo-Mutuluuza C, Adair JE, Orentas R, Dub? K. Nothing about us without us: Advocacy and engagement in genetic medicine. Sci Transl Med. 2024 May 08; 16(746):eadn2401.

View in: PubMed
Wills J, Horenstein M, Kim A, Silva MA, Dima L. Mitapivat: A Quinolone Sulfonamide to Manage Hemolytic Anemia in Adults With Pyruvate Kinase Deficiency. Am J Ther. 2023 Sep-Oct 01; 30(5):e433-e438.

View in: PubMed
Long KA, Blakey AO, Amaro CM, Eilenberg JS, Brochier A, Garg A, Drainoni ML, Pashankar F, Esrick EB, Kavanagh PL. Bidirectional processes linking social determinants of health and pediatric sickle cell anemia management: A qualitative study. Pediatr Blood Cancer. 2023 10; 70(10):e30539.

View in: PubMed
Blakey AO, Lavarin C, Brochier A, Amaro CM, Eilenberg JS, Kavanagh PL, Garg A, Drainoni ML, Long KA. Effects of Experienced Discrimination in Pediatric Sickle Cell Disease: Caregiver and Provider Perspectives. J Racial Ethn Health Disparities. 2023 12; 10(6):3095-3106.

View in: PubMed
Jean-Baptiste DM, Wassef M, Bolyai SS, Jenerette C. Individuals with Sickle Cell Disease Using SBAR as a Communication Tool: A Pilot Study. Int J Environ Res Public Health. 2022 10 24; 19(21).

View in: PubMed
Covington ML, Cone-Sullivan JK, Andrzejewski C, Lu W, Thomasson RR, O'Brien K, Brunker PAR, Stowell SR. Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement. Transfusion. 2022 08; 62(8):1662-1670.

View in: PubMed

People

Explore

Similar Concepts

Top Journals